August 26, 2014

Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co. announced that Jardiance (empagliflozin) tablets are now available by prescription in pharmacies across the United States.

August 25, 2014

DSN presents a preview of some of the hottest OTC products that appear on the show floor at NACDS Total Store Expo.

August 25, 2014

Nipro Diagnostics announced that the Food and Drug Administration approved its True Metrix self-monitoring blood-glucose system, as well as the True Metrix Pro professional monitoring blood-glucose system.

August 19, 2014

The Food and Drug Administration has granted tentative approval for Basaglar (insulin glargine injection), which is used to improve glycemic control in adults with Type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with Type 1 diabetes.

August 6, 2014

BD Medical, a segment of BD, on Wednesday announced the retail pharmacy launch of BD AutoShield Duo, the only pen needle with patented dual front- and back-end shields that provides greater convenience and safety before and after injecting. 

August 1, 2014

The Food and Drug Administration announced approval for Boehringer Ingelheim's Jardiance tablets.

July 30, 2014

GSK announced that Tanzeum (albiglutide), a once-weekly, prescription injectable treatment for Type 2 diabetes in adults, is now available in pharmacies throughout the United States.

July 16, 2014

HelpAround on Wednesday launched a mobile platform for people with diabetes — and their friends, family and caregivers — that reveals fellow ‘diabetes helpers’ from the crowd, helping people resolve sudden health crises, such as getting caught without essential over-the-counter blood glucose test strips.

June 17, 2014

The American Diabetes Association will lower its target recommendation for blood glucose levels for children with Type 1 diabetes, according to a statement released at the association's 74th Scientific Sessions.

June 16, 2014

New research presented at the June 2014 American Diabetes Association Scientific Sessions suggests that canola oil helps control blood glucose in people with Type 2 diabetes when it's incorporated into a low-glycemic index diet.

June 12, 2014

iHealth Lab on Thursday announced the launch of the iHealth Align, one of the world's smallest, FDA-approved mobile blood-glucose monitors, the company stated.

June 9, 2014

Dr. Robynne Chutkan is the founder of the Digestive Center for Women, an integrative gastroenterology practice in Chevy Chase, Maryland. She’s on the faculty at Georgetown Hospital, a former board member of the American Society for Gastrointestinal Endoscopy (ASGE), and the author of “Gutbliss: A 10-Day Plan to Ban Bloat, Flush Toxins, and Dump Your Digestive Baggage.”

April 17, 2014

Rates of five major diabetes-related complications have declined substantially in the last 20 years among U.S. adults with diabetes, according to a study by the Centers for Disease Control and Prevention, published in the current issue of the New England Journal of Medicine.

April 16, 2014

Cases of diabetes and pre-diabetes in the United States have nearly doubled since 1988, suggests new research released Tuesday from the Johns Hopkins Bloomberg School of Public Health, with obesity apparently to blame for the surge.

April 15, 2014

The Food and Drug Administration on Tuesday announced that it approved Tanzeum (albiglutide) subcutaneous injection, which is used to improve glycemic control in adults with Type 2 diabetes.

April 10, 2014

Lupin announced that it received final approval from the Food and Drug Administration for pioglitazone tablets USP in 15-mg, 30-mg and 45-mg strengths.

April 3, 2014

MannKind Corp. on Tuesday announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the Food and Drug Administration voted 13-to-1 to recommend that Afrezza (insulin human [rDNA origin]) inhalation powder be granted marketing approval by the FDA to improve glycemic control in adults with Type 1 diabetes and voted 14-to-0 to recommend that Afrezza be granted marketing approval by the FDA to improve glycemic control in adults with Type 2 diabetes.

March 27, 2014

At the American Pharmacists Association Convention on Thursday, PrescribeWellness announced a partnership with the APhA Foundation to provide community pharmacies new tools to help their diabetic patients improve their disease management and health.

March 3, 2014

AstraZeneca received approval from the Food and Drug Administration for its Bydureon pen (exenatide extended-release for injectable suspension) 2-mg, which is to be used as an addition to diet and exercise to improve glycemic control in adults with Type 2 diabetes.

February 12, 2014

America’s biopharmaceutical research companies currently are developing 180 new medicines to help the nearly 400 million people who have diabetes worldwide, the Pharmaceutical Research and Manufacturers of America announced Tuesday.

January 24, 2014

Perrigo announced that it received final approval from the Food and Drug Administration for repaglinide tablets — a generic version of Prandin tablets.

December 5, 2013

Diabetes management carries through to respondents' grocery shopping as they seek out particular products, according to a recent online survey of more than 500 AccentHealth viewers with diabetes or a family history of diabetes.

November 8, 2013

Supermarket pharmacy operators last month received validation for the growing number of diabetes educators and dietary nutritionists walking their aisles.

November 8, 2013

According to an October 2013 poll of more than 500 AccentHealth viewers with diabetes or a family history of diabetes, regular visits to the doctor, keeping a strict fitness routine and dieting are perceived to be the most important elements in managing and preventing diabetes.